American Board of Cosmetic Surgery Questions Medical Board of California's Decision to Deny Their Right to Commercial Free Speech

Wednesday, December 19, 2018 Medico Legal News
Email Print This Page Comment bookmark
Font : A-A+

With their decision, the Medical Board of California is perpetuating anti-competitive law that can negatively impact patient safety

CHICAGO, Dec. 19, 2018 /PRNewswire/ -- On December 18th, 2018, the Medical Board of

California denied the rights of exceptionally trained surgeons to advertise their board certification after they demonstrated that they meet every criteria required to state their board certification.

"The American Board of Cosmetic Surgery (ABCS) is the only certifying board dedicated exclusively to the specialty of cosmetic surgery," stated Peter Canalia, Esq. Executive Director ABCS. "We are disappointed in their decision to support legislation that limits patient choice and is a clear violation of commercial free speech and antitrust and anti-competitive laws."

With demand for elective cosmetic medical procedures increasing each year, the need for qualified, specialty trained cosmetic surgeons is critical. This is especially true given cosmetic surgery has attracted under-qualified doctors wishing to capitalize on consumer demand and profit from offering cosmetic procedures, despite minimal training in cosmetic medicine.

Many states have implemented Healthcare Truth in Advertising Laws that require doctors to clearly state their level of training and credentials in patient-facing communications. Such laws would seem to be particularly helpful for cosmetic surgery patients, who are more vulnerable to fall into the hands of unqualified doctors.

However, a few states have adopted language in their Truth in Advertising legislation that allows for a growing monopoly by one physician certifying body, placing states at risk of regulatory capture and allowing for the control of physician costs and education by one organization. This not only stifles innovation in medicine but also puts patient safety at risk. California is one such state.

In 2017, California updated its legislation that closed pathways for ABMS competing boards to advertise their board certification. Beginning January 1, 2019, no other physician certifying organizations will be permitted to advertise, thus allowing only ABMS physicians to state their board certification. The ABMS is a disproportionately powerful private physician organization—it is not a government safety organization obligated to serve the public's best interest, but rather a privately-run organization that drives this type of legislation with their own interests in mind.

To better ensure patient safety and care, the ABCS chose to combat this discriminatory legislation and protect its diplomates' right to commercial free speech by petitioning the Medical Board of California for equivalency. Essentially, equivalency demonstrates that while the ABCS is not part of the ABMS, their standards for physician training and examination are equal to or exceed that of the Medical Board of California's criteria to meet the advertising rules requirements.

Despite the fact that the ABCS exceeded the Medical Board of California's set criteria for advertising physician board certification, the MBC chose to maintain bias and deny the petition.

The denial of equivalency for board certified cosmetic surgeons in California was based on the MBC reviewer's inaccurate interpretation and conclusions regarding the American Academy of Cosmetic Surgery's (AACS) fellowship program. The AACS made multiple attempts to invite him to meet with any fellowship program director or fellow of his choice at any program. No invite was ever responded to, and many remarks within the reviewer report mirrored remarks of ABCS competitors.

"The decision to deny the American Board of Cosmetic Surgery its right to commercial free speech in California places a true danger by limiting patients' ability to choose more qualified physicians for their cosmetic surgical needs," stated Canalia. "In addition, it further perpetuates the monopoly of one physician certifying organization: the ABMS." 

By restricting ABCS surgeons from advertising their board certification, surgeons who have achieved board certification through a primary ABMS board, trained exclusively in cosmetic surgery through the fellowship program, and passed rigorous testing to earn their ABCS certification are falsely equated with non-specialty trained surgeons who opt to perform cosmetic surgery.

How this Decision Impacts Public Health & Safety Cosmetic surgery is an ever-changing and fast-growing specialty for which there is no ACGME residency in existence. Certification by the American Board of Cosmetic Surgery and American Academy of Cosmetic Surgery fellowships ensure crucial patient safety and care needs by meeting the critical demand for stringent cosmetic surgery training and continued oversight. By limiting the public's understanding of who is a safe choice, Truth in Advertising legislation serves only to perpetuate the monopoly of one organization, restrict competition, and, in doing so, create barriers for patients seeking care from safe, experienced surgeons.

The American Board of Cosmetic Surgery will continue fighting for cosmetic surgery board certification as a hallmark of specialty training, as well as to give physicians entering the field the right to pursue the most focused training in the specialty and thus better serve the public.

About American Board of Cosmetic Surgery: The American Board of Cosmetic Surgery is the only board dedicated exclusively to excellence in the specialty of cosmetic surgery. For more than 30 years, the ABCS has demonstrated the highest standards of training, knowledge, and expertise in cosmetic surgery while promoting safe and ethical practice. You can find more information about the ABCS online at

Media Contact: Neeley Dawson, (425) 689-5665

Cision View original content:

SOURCE American Board of Cosmetic Surgery

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store